BD SWITZERLAND SARL
Switzerland Last updated 25 Oct 2026
- Devices
- 172
- Registries
- EUDAMEDFDA
- FDA recalls
- 1512 ongoing
Catalogue
BD MaxPlus™ Ref MP2002C-0006
Alaris Ref 80300UNS01-035
Alaris Ref 1000SP02407
Alaris Ref 80223UNS02-52
BD MaxZero™ Ref MZ9281
BD MaxZero™ Ref MZ5310
Alaris Ref 80300UNS02-50
Phaseal Ref 515602
Alaris Ref 80223UNS02-70
BD MaxPlus™ Ref MP2005C-0006
Texium Ref MY8060-0006
BD Alaris™ Ref 500-002V
Phaseal Ref 515300
Alaris Ref 80300UNS01-30
BD MaxZero™ Ref MZ9277
Alaris Ref 80300UNS01-52
Connecta Ref 394936
Alaris Ref 80300UNS02-235
Alaris Ref 80223UNS02-32
BD MaxZero™ Ref MZ9326
BD SmartSite™ Ref 20159E7D
BD SmartSite™ Ref 2300E
BD SmartSite™ Ref 2201-0006
Alaris Ref 80300UNS02-035
Texium Ref MY8030-0006
Alaris Ref 80223UNS02-92
BD MaxZero™ Ref MZ9329
BD MaxZero™ Ref MZ5304
Alaris Ref 80300UNS01-53
BD MaxZero™ Ref MZX5302
BD SmartSite™ Ref 10013365-0006
Alaris Ref 80300UNS02-53
BD MaxZero™ Ref MZXT5307
Connecta Ref 394911
Connecta Ref 394983
Texium Ref MY8003-0006
BD SmartSite™ Ref 500-021EV
BD SmartSite™ Ref 20060E7D
BD MaxZero™ Ref MZ5305
BD MaxZero™ Ref MZ9288
BD MaxZero™ Ref MZ9279
BD SmartSite™ Ref 2205E-0006
BD MaxZero™ Ref MZ9289
BD SmartSite™ Ref 30207E
BD MaxZero™ Ref MZ9293
BD MaxZero™ Ref MZ9300
BD MaxPlus™ Ref MP2000C-0006
BD SmartSite™ Ref 2203E-0006
BD SmartSite™ Ref 2000E7D
BD MaxZero™ Ref MZX5306
Showing 51-100 of 172
EUDAMED certificates
Notified body 2797 1 certificate
- MDR 745680 Supplemented
Quality management system EU MDR
- Issued
- 27 Jul 2026
- Expires
- 3 Sep 2028
- Reason
- Change approved
Related companies
Notified bodies
- Notified body 2797
FDA recalls
2026
- 19 Aug 2026 Z-3080-2026 Class I Ongoing Due to discrepancies in specific attributes in the performance data for infusion sets, which may lead to inappropriate pump performance.
- 16 Jun 2026 Z-2941-2026 Class II Ongoing Due to mechanical issue with internal sterilization equipment resulting in potential underdosing of product during processing, which may have resulted in products not being sterilized correctly.
- 4 Jun 2026 Z-2654-2026 Class II Ongoing Due to engineering sample labeled "Not for Human Use" being inadvertently shipped it the U.S. market.
- 21 May 2026 Z-2514-2026 Class II Ongoing Due to stopcock issues when using the plastic luer-lok syringe, the connection at the Port C may over thread or continue to spin rather than tightening securely. This behavior has led some clinical users to perceive the connection as unstable.
2025
- 16 Jun 2025 Z-2453-2025 Class II Ongoing Closed system drug transfer devices were shipped to the U.S. market without a U.S. version of the instructions for use, which could be an issue if a healthcare professional is prompted to review it.
- 12 May 2025 Z-1970-2025 Class II Ongoing Sterile, single use closed system drug transfer devices, standalone or on infusion sets or bonded syringes, may leak at the interface between the closed male luer component and the needle-free connector, which may cause procedure delay, treatment interruptions, exposure to hazardous drugs, and/or underdosing of medication.
- 12 May 2025 Z-1971-2025 Class II Ongoing Sterile, single use closed system drug transfer devices, standalone or on infusion sets or bonded syringes, may leak at the interface between the closed male luer component and the needle-free connector, which may cause procedure delay, treatment interruptions, exposure to hazardous drugs, and/or underdosing of medication.
- 12 May 2025 Z-1972-2025 Class II Ongoing Sterile, single use closed system drug transfer devices, standalone or on infusion sets or bonded syringes, may leak at the interface between the closed male luer component and the needle-free connector, which may cause procedure delay, treatment interruptions, exposure to hazardous drugs, and/or underdosing of medication.
- 12 May 2025 Z-1973-2025 Class II Ongoing Sterile, single use closed system drug transfer devices, standalone or on infusion sets or bonded syringes, may leak at the interface between the closed male luer component and the needle-free connector, which may cause procedure delay, treatment interruptions, exposure to hazardous drugs, and/or underdosing of medication.
- 12 May 2025 Z-1974-2025 Class II Ongoing Sterile, single use closed system drug transfer devices, standalone or on infusion sets or bonded syringes, may leak at the interface between the closed male luer component and the needle-free connector, which may cause procedure delay, treatment interruptions, exposure to hazardous drugs, and/or underdosing of medication.
Show all 15 recalls
2025
- 20 Feb 2025 Z-1509-2025 Class II Ongoing Due to specific lots of luer-lok devices were shipped to the U.S. market with an Outside US Instruction for Use (IFU)
2024
- 18 Apr 2024 Z-1944-2024 Class II Ongoing Due to infusion set tubing drip chamber becoming detached from the tubing potentially causing delays in treatment, or unintentionally exposing users to harsh infusates.
2020
- 9 Apr 2020 Z-1967-2020 Class II Terminated The products have the potential to leak between the connection of the male luer and the yellow striped tubing. This leak may be observed while priming or during use. The most likely health consequence associated with a leak in an administration set would be inadequate pain control for the patient due to an under-infusion of medication.
- 9 Apr 2020 Z-1968-2020 Class II Terminated The products have the potential to leak between the connection of the male luer and the yellow striped tubing. This leak may be observed while priming or during use. The most likely health consequence associated with a leak in an administration set would be inadequate pain control for the patient due to an under-infusion of medication.
- 9 Apr 2020 Z-1969-2020 Class II Terminated The products have the potential to leak between the connection of the male luer and the yellow striped tubing. This leak may be observed while priming or during use. The most likely health consequence associated with a leak in an administration set would be inadequate pain control for the patient due to an under-infusion of medication.
Frequently asked questions
How many devices does BD SWITZERLAND SARL have in the registry?
The registry currently lists 172 devices for BD SWITZERLAND SARL. Devices recorded under merged duplicate company entries are counted once.
Are there FDA recall records for BD SWITZERLAND SARL?
FDA recall records list 15 recalls initiated by BD SWITZERLAND SARL, the most recent initiated on 2026-08-19. 12 of them are recorded as ongoing. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.
What EUDAMED certificates are recorded for BD SWITZERLAND SARL?
EUDAMED lists 1 certificate for BD SWITZERLAND SARL (quality management system) under MDR. The most recent was issued on 2026-07-27.
Information
- Address
- 17, Route de Crassier, Eysins, Switzerland
- Website
- www.bd.com
- [email protected]
- Phone
- +41 21 556 30 00
- PRRC contact
- Michael Campbell
- EUDAMED SRN
- CH-MF-000026539
- FDA FEI number
- 3012798826